Show simple item record

dc.contributor.authorBalague Ponz, Olga
dc.contributor.authorOtt, German
dc.contributor.authorHasserjian, Robert Paul
dc.contributor.authorElenitoba-Johnson, Kojo S. J.
dc.contributor.authorde Leval, Laurence
dc.contributor.authorde Jong, Daphne
dc.date.accessioned2011-02-20T15:47:08Z
dc.date.issued2009
dc.identifier.citationBalague Ponz, Olga, German Ott, Robert P. Hasserjian, Kojo S. J. Elenitoba-Johnson, Laurence de Leval, and Daphne de Jong. 2009. Commentary on the WHO classification of tumors of lymphoid tissues (2008): Aggressive B-cell lymphomas. Journal of Hematopathology 2(2): 83-87.en_US
dc.identifier.issn1865-5785en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:4728486
dc.description.abstractIn the novel WHO classification 2008, the classification of aggressive B-cell lymphoma has been revised for several categories with the aim to define “clean” entities. Within large B-cell lymphoma, a few distinct clinico-pathological entities have been recognized with more clinically defined entities than pathologically defined ones. The majority of known morphological variations were not considered to merit more than classification as a variant of DLBCL, not otherwise specified. Specifically, a biological subgrouping of DLBCL on the basis of molecular (activated B-cell versus germinal center B-cell) or immunophenotypic (CD5+) features was felt to be too immature to include at this stage. The role of EBV in aggressive B-cell lymphoma has been explored in more depth with the recognition of several novel and re-defined clinico-pathological entities. Also, in these diseases, clinical definitions play a very dominant role in the WHO classification 2008.en_US
dc.language.isoen_USen_US
dc.publisherSpringer Verlagen_US
dc.relation.isversionofdoi:10.1007/s12308-009-0038-8en_US
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725286/pdf/en_US
dash.licenseLAA
dc.subjectdiffuse large B-cell lymphomaen_US
dc.subjectclinico-pathological entityen_US
dc.subjectEBVen_US
dc.subjectimmunodeficiencyen_US
dc.subjectclassificationen_US
dc.subjectWHOen_US
dc.titleCommentary on the WHO Classification of Tumors of Lymphoid Tissues (2008): Aggressive B-cell Lymphomasen_US
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden_US
dc.relation.journalJournal of Hematopathologyen_US
dash.depositing.authorHasserjian, Robert Paul
dc.date.available2011-02-20T15:47:08Z
dash.affiliation.otherHMS^Pathologyen_US
dc.identifier.doi10.1007/s12308-009-0038-8*
dash.contributor.affiliatedHasserjian, Robert


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record